Your trusted source for investing success

Tag: research

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
Australian Governments to Streamline Access to Medical Cannabis

Australian Governments to Streamline Access to Medical Cannabis

PUF Ventures Inc. (“PUF” or the “Company”) (CSE:PUF) (Frankfurt:PU3) (OTCPK:PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce its full support of the Council of Australian Governments and their recent decision to significantly reduce the wait time for medical cannabis patients.

Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series

Cesca Therapeutics (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that it has entered into an evaluation agreement with the University of North Carolina Lineberger Advanced Cellular Therapeutics Facility (ACT) to assess Cesca’s patented and proprietary X-Series products for automated, closed system cellular

CrossLayerTM, an FTE Networks Subsidiary, Expands Edge Compute Platform

FTE Networks Inc (NYSE:FTNW), a leading provider of innovative technology oriented solutions for network, data and intelligent building infrastructure announced that its subsidiary, CrossLayer is expanding the capabilities of its software-driven, multi-access, edge compute platform with Cumulus Networks.

As quoted in the press release:

“CrossLayer’s converged edge compute and network infrastructure provides

VIQ Solutions Inc. Reports Full Year 2017 Results

VIQ Solutions Inc (TSXV:VQS), a global expert in providing cybersecurity protected technology and service platform for digital evidence reported its financial results for the year ended December 31, 2017.

The company said that the consolidated revenue was approximately $11.7 million which represented 36 per cent growth over the previous year.

As quoted

Canntab Provides Corporate Update

Canntab Provides Corporate Update

Canntab Therapeutics Limited (CSE: PILL) (“Canntab” or the “Company”) is pleased to announce two recent developments: (i) an update on its application for a Dealer’s License with Health Canada; and (ii) its Australian joint venture partner has obtained a license to import medical cannabis products.

2018 Energy Market Report

Download your report to see how battery tech and oil markets will do this year.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
Emblem Looking to Reach Adult Cannabis Consumers Through Education